CRSP - Financial Reports List - CRISPR Therapeutics AG - IntrinsicAlpha

CRISPR Therapeutics AG CRSP

Healthcare - Biotechnology - NASDAQ - CH

$ 39.215

0.132 %

$ 3.38 B

Market Cap

-8.71

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-82.50%	-41.76%	-92.82%
Annual Report	FY	10-K	2024-12-31	-90.57%	-138.43%	-109.66%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	23.37%	16.83%
Quarterly Report	Q2	8-K	2024-06-30	-99.26%	-62.60%	-58.85%
Quarterly Report	Q1	8-K	2024-03-31	-99.50%	-119.71%	-118.01%
Quarterly Report	Q4	8-K	2023-12-31	3333233.33%	180.80%	152.90%
Annual Report	FY	10-K	2023-12-31	85038.99%	76.37%	66.94%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	35.75%	27.40%
Quarterly Report	Q2	8-K	2023-06-30	44203.80%	58.17%	48.04%
Quarterly Report	Q1	8-K	2023-03-31	56079.78%	70.39%	63.35%

1